Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 3, Issue 2, 2007, Pages 161-167

  Esmaeili, Farnaz ^a   Hosseini Nasr, Mahdi ^a   Rad Malekshahi, Mazda ^a   Samadi, Nasrin ^b   Atyabi, Fatemeh ^a   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibacterial activity; Antimicrobial delivery; Nanoparticles; Poly lactide co glycolide; Rifampicin

Indexed keywords

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL DELIVERY; POLY LACTIDECOGLYCOLIDES (PLGA); RIFAMPICIN;

ANTIBIOTICS; BACTERIA; ENCAPSULATION; PARTICLE SIZE ANALYSIS; PHASE COMPOSITION; POLYVINYL ALCOHOLS; SURFACE ACTIVE AGENTS;

NANOPARTICLES;

NANOPARTICLE; POLYGLACTIN; POLYVINYL ALCOHOL; RESOMER 504; RIFAMPICIN; SOLVENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DIFFUSION; DRUG SCREENING; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NANOENCAPSULATION; PARTICLE SIZE;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; LACTIC ACID; MATERIALS TESTING; NANOPARTICLES; POLYGLYCOLIC ACID; POLYMERS; RIFAMPIN;

NEGIBACTERIA; POSIBACTERIA;

EID: 34250328300     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2007.03.003     Document Type: Article

References (27)

1. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital-Florida. MMWR Morb Mortal Wkly Rep 39 (1990) 718-722
2. Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49 (2000) 1-51
3. Dutt M., and Khuller G.K. Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro-in vivo study. Int J Antimicrob Agents 18 (2001) 245-252
4. Sharma R., Saxena D., Dwivedi A.K., and Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res 18 (2001) 1405-1410
5. Maincent P., Thouvenot P., Amicabile C., Hoffman M., Kreuter J., Couvreur P., et al. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res 9 (1992) 1534-1539
6. Nakada Y., Fattal E., Foulquier M., and Couvreur P. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm Res 13 (1996) 38-43
7. Kreuter J. Drug targeting with nanoparticles. Eur J Drug Metab Pharmacokinet 19 (1994) 253-256
8. Couvreur P., Couarraze G., Devissaguet J.P., and Puisieux F. Nanoparticles: preparation and characterisation. In: Benita S. (Ed). Microencapsulation: methods and industrial application (1996), Marcel Dekker, New York 183-211
9. Kreuter J. Nanoparticles. In: Kreuter J. (Ed). Colloidal drug delivery systems (1994), Marcel Dekker, New York 219-342
10. Knight C.G. Liposomes from physical structure to therapeutic applications (1981), Elsevier, Amsterdam
11. Dalencon F., Amjaud Y., Lafforgue C., Derouin F., and Fessi H. Atovaquone and rifabutine-loaded nanocapsules: formulation studies. Int J Pharm 153 (1997) 127-130
12. Lopes E., Pohlmann A.R., Bassani V., and Guterres S.S. Polymeric colloidal systems containing ethionamide: preparation and physico-chemical characterization. Pharmazie 55 (2000) 527-530
13. Suarez S., O'Hara P., Kazantseva M., Newcomer C.E., Hopfer R., McMurray D.N., et al. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother 48 (2001) 431-434
14. Pandey R., Sharma A., Zahoor A., Sharma S., Khuller G.K., and Prasad B. Poly (d,l-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother 52 (2003) 981-986
15. Pandey R., Sharma S., and Khuller G.K. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 85 (2005) 415-420
16. Bivas-Benita M., Van Meijgaarden K.E., Franken K.L., Junginger H.E., Borchard G., Ottenhoff T.H., et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 22 (2004) 1609-1615
17. Niwa T., Takeuchi H., Hino T., Kunou N., and Kawashima Y. In vitro drug release behavior of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J Pharm Sci 83 (1994) 727-732
18. Denkbas E.B., Kaitian X., Tuncel A., and Piskin E. Rifampicin-carrying poly(d,l-lactide) microspheres: loading and release. J Biomater Sci Polym Ed 6 (1995) 815-825
19. Quintanar-Guerrero D., Fessi H., Allemann E., and Doelker E. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm 143 (1996) 133-141
20. Choi S.W., Kwon H.Y., Kim W.S., and Kim J.H. Thermodynamic parameters on poly(d,l-lactide-co-glycolide) particle size in emulsification-diffusion process. Colloids Surf Physicochem Eng Asp b201 (2002) 283-289
21. Alex R., and Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J Microencapsul 7 (1990) 347-355
22. Blanco M.D., and Alonso M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 43 (1997) 287-294
23. Iwata M., and McGinity J.W. Preparation of multi-phase microspheres of poly(d,l-lactic acid) and poly(d,l-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. J Microencapsul 9 (1992) 201-214
24. Feng S.S., and Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 71 (2001) 53-69
25. Ricci M., Blasi P., Giovagnoli S., Perioli L., Vescovi C., and Rossi C. Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation. Int J Pharm 275 (2004) 61-72
26. Holland S.J., and Tighe B.J. Biodegradable polymers. In: Garderton D., and Jones T. (Eds). Advanced pharmaceutical sciences Vol. 6 (1992), Academic Press, New York 101-164
27. In: Reynolds J.E.F. (Ed). Martindale, the extra pharmacopoeia. 31st ed. Vol. 1 (1996), The Royal Pharmaceutical Society of Great Britain, London 268-271